HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Health-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: A prospective cohort study.

AbstractOBJECTIVE:
Impaired quality of life (QoL) in primary hyperparathyroidism (PHPT) is commonly present. Patients may complain about nonspecific neurocognitive symptoms which can be difficult to quantify. Two different disease-specific questionnaires have been developed, that is, the parathyroid assessment of symptoms score (PAS) and the primary hyperparathyroidism quality of life (PHPQoL). Using these two questionnaires, we assessed relationship between QoL and biochemical indices in PHPT and effects of parathyroidectomy (PTX).
DESIGN:
A prospective cohort study.
METHODS:
Patients with PHPT diagnosed from 2015 to 2017 were asked to answer the questionnaires before and 12 months after PTX. Biochemistry was obtained on both occasions.
RESULTS:
A total of 104 PHPT patients answered PAS and PHPQoL questionnaires at baseline, with a median age of 64 years (73% females). PHPQoL score correlated inversely with ionized calcium and PTH at baseline (P ˂ 0.04). Total PAS and PHPQoL score did not differ between those with and without osteoporosis, renal calcifications and impaired renal function. Based on levels of ionized calcium, PHPQoL differed significantly between patients with mild- and moderate-severe hypercalcemia (P = 0.01). Fifty-three patients answered PAS and PHPQoL 12 months after PTX showing an improved QoL at follow-up (Pall  ˂ 0.02). Stratifying patients into groups based on levels of ionized calcium showed a significantly improved PHPQoL score in patients with mild (˂1.45 mmol/L) as well as moderate-severe hypercalcemia (≥1.45 mmol/L) at follow-up (Pall  ˂ 0.03).
CONCLUSION:
Quality of life improved 12 months after PTX in PHPT patients. Impaired QoL seems to be associated with the degree of hypercalcemia rather than organ manifestations attributable to PHPT.
AuthorsHenriette Ejlsmark-Svensson, Tanja Sikjaer, Susan M Webb, Lars Rejnmark, Lars Rolighed
JournalClinical endocrinology (Clin Endocrinol (Oxf)) Vol. 90 Issue 1 Pg. 184-191 (01 2019) ISSN: 1365-2265 [Electronic] England
PMID30267589 (Publication Type: Journal Article)
Copyright© 2018 John Wiley & Sons Ltd.
Chemical References
  • Calcium
Topics
  • Adult
  • Calcium (blood, pharmacology)
  • Cohort Studies
  • Female
  • Humans
  • Hypercalcemia
  • Hyperparathyroidism, Primary (psychology, surgery)
  • Male
  • Middle Aged
  • Parathyroidectomy (methods)
  • Prospective Studies
  • Quality of Life
  • Surveys and Questionnaires

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: